OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prognostic relevance of androgen receptor expression in renal cell carcinomas
Sebastian Foersch, Mario Schindeldecker, Martina Keith, et al.
Oncotarget (2017) Vol. 8, Iss. 45, pp. 78545-78555
Open Access | Times Cited: 24
Sebastian Foersch, Mario Schindeldecker, Martina Keith, et al.
Oncotarget (2017) Vol. 8, Iss. 45, pp. 78545-78555
Open Access | Times Cited: 24
Showing 24 citing articles:
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma
Philipp Stenzel, Mario Schindeldecker, Katrin E. Tagscherer, et al.
Translational Oncology (2019) Vol. 13, Iss. 2, pp. 336-345
Open Access | Times Cited: 66
Philipp Stenzel, Mario Schindeldecker, Katrin E. Tagscherer, et al.
Translational Oncology (2019) Vol. 13, Iss. 2, pp. 336-345
Open Access | Times Cited: 66
Lamin‑B1 is a senescence‑associated biomarker in clear‑cell renal cell carcinoma
Melissa Radspieler, Mario Schindeldecker, Philipp Stenzel, et al.
Oncology Letters (2019)
Open Access | Times Cited: 38
Melissa Radspieler, Mario Schindeldecker, Philipp Stenzel, et al.
Oncology Letters (2019)
Open Access | Times Cited: 38
SPOP, ZEB-1 and E-cadherin expression in clear cell renal cell carcinoma (cc-RCC): Clinicopathological and prognostic significance
Ola A. Harb, Mariem A. Elfeky, Basant Sh El Shafaay, et al.
Pathophysiology (2018) Vol. 25, Iss. 4, pp. 335-345
Closed Access | Times Cited: 34
Ola A. Harb, Mariem A. Elfeky, Basant Sh El Shafaay, et al.
Pathophysiology (2018) Vol. 25, Iss. 4, pp. 335-345
Closed Access | Times Cited: 34
Y box binding protein 1 (YB-1) oncoprotein at the hub of DNA proliferation, damage and cancer progression
Felicia Sangermano, Antonella Delicato, Viola Calabrò
Biochimie (2020) Vol. 179, pp. 205-216
Closed Access | Times Cited: 28
Felicia Sangermano, Antonella Delicato, Viola Calabrò
Biochimie (2020) Vol. 179, pp. 205-216
Closed Access | Times Cited: 28
Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity
Kyoung Hwa Lee, Byung-Chan Kim, Seung‐hwan Jeong, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6089-6089
Open Access | Times Cited: 26
Kyoung Hwa Lee, Byung-Chan Kim, Seung‐hwan Jeong, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6089-6089
Open Access | Times Cited: 26
Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development
Kimberley Katleba, P. Ghosh, Maria Mudryj
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2215-2215
Open Access | Times Cited: 9
Kimberley Katleba, P. Ghosh, Maria Mudryj
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2215-2215
Open Access | Times Cited: 9
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer
Alessia Cimadamore, Silvia Gasparrini, Matteo Santoni, et al.
Expert Review of Molecular Diagnostics (2018) Vol. 18, Iss. 7, pp. 645-655
Closed Access | Times Cited: 21
Alessia Cimadamore, Silvia Gasparrini, Matteo Santoni, et al.
Expert Review of Molecular Diagnostics (2018) Vol. 18, Iss. 7, pp. 645-655
Closed Access | Times Cited: 21
In Silico Exploration of AHR-HIF Pathway Interplay: Implications for Therapeutic Targeting in ccRCC
Francesco Gregoris, Giovanni Minervini, Silvio C. E. Tosatto
Genes (2024) Vol. 15, Iss. 9, pp. 1167-1167
Open Access | Times Cited: 2
Francesco Gregoris, Giovanni Minervini, Silvio C. E. Tosatto
Genes (2024) Vol. 15, Iss. 9, pp. 1167-1167
Open Access | Times Cited: 2
Novel molecular signatures and potential therapeutics in renal cell carcinomas: Insights from a comparative analysis of subtypes
Aysegul Caliskan, Ahmet Cenk Andac, Kazım Yalçın Arğa
Genomics (2020) Vol. 112, Iss. 5, pp. 3166-3178
Open Access | Times Cited: 13
Aysegul Caliskan, Ahmet Cenk Andac, Kazım Yalçın Arğa
Genomics (2020) Vol. 112, Iss. 5, pp. 3166-3178
Open Access | Times Cited: 13
Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer
Joanna Białek, Maria Piwonka, Felix Kawan, et al.
Life (2021) Vol. 11, Iss. 8, pp. 731-731
Open Access | Times Cited: 11
Joanna Białek, Maria Piwonka, Felix Kawan, et al.
Life (2021) Vol. 11, Iss. 8, pp. 731-731
Open Access | Times Cited: 11
Frequent gene mutations and the correlations with clinicopathological features in clear cell renal cell carcinoma: preliminary study based on Chinese population and TCGA database
Qiang Zhao, Baoan Hong, Xuezhou Zhang, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Qiang Zhao, Baoan Hong, Xuezhou Zhang, et al.
BMC Urology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The influence of sex hormones on renal cell carcinoma
Michael Ladurner, Andrea Katharina Lindner, Peter Rehder, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Michael Ladurner, Andrea Katharina Lindner, Peter Rehder, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
A metagene based similarity network fusion approach for multi-omics data integration identified novel subtypes in renal cell carcinoma
Congcong Jia, Tong Wang, Dan Cui, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 6
Open Access | Times Cited: 1
Congcong Jia, Tong Wang, Dan Cui, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 6
Open Access | Times Cited: 1
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities
G. Paolo Dotto, An Buckinx, Berna C. Özdemir, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 1
G. Paolo Dotto, An Buckinx, Berna C. Özdemir, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 1
The Association of Androgen Receptor Expression with Renal Cell Carcinoma Risk: a Systematic Review and Meta-Analysis
Peng Yuan, Yue Ge, Xiao Liu, et al.
Pathology & Oncology Research (2019) Vol. 26, Iss. 2, pp. 605-614
Closed Access | Times Cited: 10
Peng Yuan, Yue Ge, Xiao Liu, et al.
Pathology & Oncology Research (2019) Vol. 26, Iss. 2, pp. 605-614
Closed Access | Times Cited: 10
CD15 Is a Risk Predictor and a Novel Target in Clear Cell Renal Cell Carcinoma
Philipp Stenzel, Mario Schindeldecker, Larissa Seidmann, et al.
Pathobiology (2023) Vol. 91, Iss. 3, pp. 219-229
Open Access | Times Cited: 3
Philipp Stenzel, Mario Schindeldecker, Larissa Seidmann, et al.
Pathobiology (2023) Vol. 91, Iss. 3, pp. 219-229
Open Access | Times Cited: 3
A pan‐cancer integrative pathway analysis of multi‐omics data
Henry Linder, Yuping Zhang
Quantitative Biology (2020) Vol. 8, Iss. 2, pp. 130-142
Open Access | Times Cited: 4
Henry Linder, Yuping Zhang
Quantitative Biology (2020) Vol. 8, Iss. 2, pp. 130-142
Open Access | Times Cited: 4
Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts
Mariam M. Konaté, Ming‐Chung Li, Lisa M. McShane, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Mariam M. Konaté, Ming‐Chung Li, Lisa M. McShane, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy
Lucia Osorio, Tatiana P. Grazioso, Guillermo de Velasco, et al.
Clinical & Translational Oncology (2024)
Closed Access
Lucia Osorio, Tatiana P. Grazioso, Guillermo de Velasco, et al.
Clinical & Translational Oncology (2024)
Closed Access
Renal cell carcinoma: a systematic review and meta-analysis on expression of androgen receptor
Hossein Abdi, Hamid Reza Mozaffari, Mehrdad Payandeh, et al.
Biomedical Research and Therapy (2018) Vol. 5, Iss. 11, pp. 2820-2826
Open Access | Times Cited: 1
Hossein Abdi, Hamid Reza Mozaffari, Mehrdad Payandeh, et al.
Biomedical Research and Therapy (2018) Vol. 5, Iss. 11, pp. 2820-2826
Open Access | Times Cited: 1
Prostate cancer morbidity in the Mari El Republic: A retrospective observational study
D. V. Pasynkov, R. I. Fatykhov
Kuban Scientific Medical Bulletin (2023) Vol. 30, Iss. 6, pp. 56-65
Open Access
D. V. Pasynkov, R. I. Fatykhov
Kuban Scientific Medical Bulletin (2023) Vol. 30, Iss. 6, pp. 56-65
Open Access
Androgen receptors: unclear ubiquitious mechanism or the missing key in the triple–negative breast cancer?
Ana Tečić Vuger, Robert Šeparović, Ljubica Vazdar, et al.
Libri Oncologici Croatian Journal of Oncology (2020) Vol. 48, Iss. 1, pp. 20-26
Open Access
Ana Tečić Vuger, Robert Šeparović, Ljubica Vazdar, et al.
Libri Oncologici Croatian Journal of Oncology (2020) Vol. 48, Iss. 1, pp. 20-26
Open Access
Endocrine Disruptors and Cancer: From Genotoxicity Mechanisms to Ethnicity-related Susceptibility
Aleksandra Fučić, Philippa D. Darbre
The Royal Society of Chemistry eBooks (2020), pp. 197-217
Closed Access
Aleksandra Fučić, Philippa D. Darbre
The Royal Society of Chemistry eBooks (2020), pp. 197-217
Closed Access
Controlled ovarian stimulation therapy as a potential risk for the development and progression of renal cell carcinomas: A case report and literature review
Sotirios G. Doukas, Boris Martinez, Marnie Rosenthal, et al.
Molecular and Clinical Oncology (2021) Vol. 15, Iss. 1
Open Access
Sotirios G. Doukas, Boris Martinez, Marnie Rosenthal, et al.
Molecular and Clinical Oncology (2021) Vol. 15, Iss. 1
Open Access
